Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2015 | 08-2015 | 05-2015 | 02-2015 | 11-2014 | |
| Operating Expenses | 2,449 | 0 | 1,634 | 1,674 | 1,902 |
| Operating Income | -2,449 | N/A | -1,634 | -1,674 | -1,902 |
| Interest Expense | 17 | 0 | 0 | 1 | 21 |
| Other Income | 76 | 0 | 51 | 38 | 27 |
| Pre-tax Income | -2,390 | 0 | -1,583 | -1,637 | -1,896 |
| Net Income Continuous | -2,390 | N/A | -1,583 | -1,637 | -1,896 |
| Net Income | $-2,390 | $N/A | $-1,583 | $-1,637 | $-1,896 |
| EPS Basic Total Ops | -0.21 | N/A | -0.15 | -0.15 | -0.19 |
| EPS Basic Continuous Ops | -0.21 | N/A | -0.15 | -0.15 | -0.19 |
| EPS Diluted Total Ops | -0.21 | N/A | -0.15 | -0.15 | -0.19 |
| EPS Diluted Continuous Ops | -0.21 | N/A | -0.15 | -0.15 | -0.19 |
| EBITDA(a) | $-2,446 | $N/A | $-1,633 | $-1,671 | $-1,901 |